Convenient and accurate quantification of disease-relevant multitargets is essential for
community disease screening. However, in the field of photoelectrochemical (PEC) sensors …

Alzheimer's disease (AD) is a neurodegenerative disorder initiated by amyloid-beta (Aβ)
accumulation, leading to impaired cognitive function. Several delivery approaches have …

Given the complexity of the central nervous system (CNS) and the diversity of neurological
conditions, the increasing prevalence of neurological disorders poses a significant …

Background Glioblastoma multiforme (GBM) is an aggressive tumor, difficult to treat
pharmacologically because of the blood-brain barrier (BBB), which is rich in ATP-binding …

Central nervous system (CNS) diseases including depression, stroke, brain infection, brain
cancer, neurodegenerations, meningitis, neuropathic pain, amyotrophic lateral sclerosis …

Alzheimer's disease (AD) holds global significance as a neurodegenerative disorder with a
complex etiology still partly understood. Recent advancements in genetic and molecular …

Despite wide applications of CRISPR/Cas9 technology, effective approaches for CRISPR
delivery with functional control are limited. In an attempt to develop a nanoscale …

Abstract The LDL Receptor-Related Protein 1 (LRP1), a member of the Low-density
Lipoprotein (LDL) receptor family, is a multifunctional cellular transporter and signaling …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no effective
disease-modifying treatments. The blood–brain barrier hinders drug delivery to the brain …

With the deepening of Alzheimer's disease (AD) research, serum miRNA has attracted
widespread attention as a potential biomarker. Traditional diagnostic methods for AD have …